Belatacept: is there BENEFIT for liver transplantation too?

Other Article (Editorial)

The results of the multicenter belatacept liver transplant trial disappoint with respect to safety and efficacy, and new approaches will be required before this agent plays a role in liver transplant immunosuppression. See article by Klintmalm et al on page 1817.

Full Text

Duke Authors

Cited Authors

  • Knechtle, SJ; Adams, AB

Published Date

  • August 2014

Published In

Volume / Issue

  • 14 / 8

Start / End Page

  • 1717 - 1718

PubMed ID

  • 25041120

Electronic International Standard Serial Number (EISSN)

  • 1600-6143

Digital Object Identifier (DOI)

  • 10.1111/ajt.12806


  • eng

Conference Location

  • United States